Surgisphere: Difference between revisions

Latest revision as of 11:14, 15 February 2025

Surgisphere company logo

Surgisphere Corporation is a healthcare analytics company that gained significant attention in 2020 due to its involvement in controversial studies related to COVID-19. The company was founded in 2008 by Dr. Sapan Desai and is headquartered in the United States.

History[edit]

Surgisphere was established with the aim of improving healthcare outcomes through advanced data analytics. Initially, the company focused on providing services to hospitals and healthcare providers, offering tools for data management and analysis.

Early Years[edit]

In its early years, Surgisphere developed a range of products designed to assist healthcare professionals in making data-driven decisions. These products included electronic health record systems and clinical decision support tools.

COVID-19 Controversy[edit]

In 2020, Surgisphere became embroiled in controversy when studies it provided data for were published in prominent medical journals, including The Lancet and The New England Journal of Medicine. These studies claimed to analyze data from thousands of COVID-19 patients worldwide, assessing the effects of certain treatments.

File:Surgisphere company logo.png

Surgisphere's involvement in COVID-19 studies led to scrutiny.

Retraction of Studies[edit]

The studies were retracted after questions arose regarding the validity and source of the data. Concerns were raised about the lack of transparency and the inability of independent researchers to verify the data. This led to widespread criticism and scrutiny of Surgisphere's practices.

Products and Services[edit]

Surgisphere offers a variety of products aimed at enhancing healthcare delivery through data analytics. These include:

Healthcare Data Analytics: Tools for analyzing large datasets to improve patient outcomes.
Clinical Decision Support: Systems designed to assist healthcare providers in making informed clinical decisions.
Electronic Health Records: Solutions for managing patient information efficiently.

Impact on Medical Research[edit]

The Surgisphere controversy highlighted the importance of data transparency and integrity in medical research. It underscored the need for rigorous peer review and verification processes, especially when studies have significant implications for public health.

Related pages[edit]

@@ Line 1: / Line 1: @@
-'''Strephosymbolia''' is a [[learning disability]] that is characterized by difficulties in recognizing and interpreting symbols. It is a rare condition that is often associated with [[dyslexia]] and other [[learning disorders]].
+{{DISPLAYTITLE:Surgisphere}}
+[[File:Surgisphere_company_logo.png|thumb|right|Surgisphere company logo]]
-==Definition==
+'''Surgisphere Corporation''' is a healthcare analytics company that gained significant attention in 2020 due to its involvement in controversial studies related to COVID-19. The company was founded in 2008 by Dr. Sapan Desai and is headquartered in the United States.
-Strephosymbolia is a term that was first coined by Dr. [[Samuel T. Orton]] in the 1920s. It is derived from the Greek words "strephos" (twisted) and "symbolia" (symbols), and it refers to a condition where an individual has difficulty interpreting symbols, such as letters and numbers. This can affect a person's ability to read, write, and do math.
-==Symptoms==
+==History==
-The symptoms of strephosymbolia can vary greatly from person to person. However, some common symptoms include:
+Surgisphere was established with the aim of improving healthcare outcomes through advanced data analytics. Initially, the company focused on providing services to hospitals and healthcare providers, offering tools for data management and analysis.
-* Difficulty recognizing letters and numbers
-* Problems with reading and writing
-* Difficulty with math
-* Problems with spatial orientation
-* Difficulty with fine motor skills
-==Causes==
+===Early Years===
-The exact cause of strephosymbolia is unknown. However, it is believed to be related to abnormalities in the [[brain]]'s processing of visual and auditory information. It is also thought to be hereditary, as it often runs in families.
+In its early years, Surgisphere developed a range of products designed to assist healthcare professionals in making data-driven decisions. These products included electronic health record systems and clinical decision support tools.
-==Diagnosis==
+===COVID-19 Controversy===
-Diagnosis of strephosymbolia is typically made through a series of tests that assess a person's reading, writing, and math skills. These tests can include:
+In 2020, Surgisphere became embroiled in controversy when studies it provided data for were published in prominent medical journals, including ''The Lancet'' and ''The New England Journal of Medicine''. These studies claimed to analyze data from thousands of COVID-19 patients worldwide, assessing the effects of certain treatments.
-* [[Psychoeducational testing]]
-* [[Neuropsychological testing]]
-* [[Speech and language testing]]
-==Treatment==
+[[File:Surgisphere_company_logo.png|thumb|left|Surgisphere's involvement in COVID-19 studies led to scrutiny.]]
-Treatment for strephosymbolia typically involves specialized educational interventions. These can include:
-* [[Special education]] programs
-* [[Speech therapy]]
-* [[Occupational therapy]]
-* [[Physical therapy]]
-==See also==
+====Retraction of Studies====
-* [[Dyslexia]]
+The studies were retracted after questions arose regarding the validity and source of the data. Concerns were raised about the lack of transparency and the inability of independent researchers to verify the data. This led to widespread criticism and scrutiny of Surgisphere's practices.
-* [[Learning disability]]
-* [[Special education]]
-==References==
+==Products and Services==
-<references />
+Surgisphere offers a variety of products aimed at enhancing healthcare delivery through data analytics. These include:
-{{stub}}
+* '''Healthcare Data Analytics''': Tools for analyzing large datasets to improve patient outcomes.
+* '''Clinical Decision Support''': Systems designed to assist healthcare providers in making informed clinical decisions.
+* '''Electronic Health Records''': Solutions for managing patient information efficiently.
-[[Category:Learning disabilities]]
+==Impact on Medical Research==
-[[Category:Neurological disorders]]
+The Surgisphere controversy highlighted the importance of data transparency and integrity in medical research. It underscored the need for rigorous peer review and verification processes, especially when studies have significant implications for public health.
-[[Category:Special education]]
+==Related pages==
+* [[COVID-19 pandemic]]
+* [[Data analytics in healthcare]]
+* [[Medical research]]
+* [[Retraction (academic publishing)]]
+[[Category:Healthcare companies]]
+[[Category:Data analytics]]
+[[Category:COVID-19 pandemic]]